SDPS-32 A CLINICALLY COMPATIBLE IN VITRO DRUG-SCREENING PLATFORM IDENTIFIES THERAPEUTIC VULNERABILITIES IN PRIMARY CULTURES OF BRAIN METASTASES

Approximately 20% of cancer patients (including lung, melanoma, breast, renal, and colorectal cancer patients) develop brain metastases. Current systemic therapies often show limited efficacy for brain metastasis treatment and support palliative care only. In this preclinical study, short-term cultu...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeising, Sebastian, Trübel, Johanna, Felsberg, Jörg, Picard, Daniel, Wolter, Marietta, Kaulich, Kerstin, Häberle, Lena, Esposito, Irene, Steinmann, Julia, Beez, Thomas, Rapp, Marion, Sabel, Michael, Nickel, Ann-Christin, Remke, Marc, Reifenberger, Guido, Qin, Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Final Category: Screening/Diagnostics/Prognostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402350/
http://dx.doi.org/10.1093/noajnl/vdad070.087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402350/
http://dx.doi.org/10.1093/noajnl/vdad070.087

Ejemplares similares